SCHEMBL30895162

SCHEMBL30895162

O=C(NCc1ccc2c(c1)SCCN2c1ccccc1)Nc1ccc2cc[nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.44
FAAH O00519 1/20 0.40
DDB1 Q16531 2/20 0.40
CRBN Q96SW2 2/20 0.40
KDM4E B2RXH2 1/20 0.39
NAMPT P43490 1/20 0.39
MAPT P10636 3/20 0.39
GAA P10253 2/20 0.39
ROCK1 Q13464 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 2/20 0.38
NLRP3 Q96P20 1/20 0.38
METTL3 Q86U44 1/20 0.38
METTL14 Q9HCE5 1/20 0.38
CFTR P13569 1/20 0.38
GABRA1 P14867 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25028041 1.00 ROCK2 (0.44) ROCK2FAAHDDB1CRBNKDM4E
SCHEMBL30248570 0.95 FAAH (0.44) ROCK2FAAHDDB1CRBNKDM4E
SCHEMBL25028038 0.95 FAAH (0.44) ROCK2FAAHDDB1CRBNKDM4E
SCHEMBL23768831 0.89 ESR1 (0.40) FAAHKDM4EMAPTMEN1NPC1
SCHEMBL29978704 0.89 ESR1 (0.40) FAAHKDM4EMAPTMEN1NPC1
SCHEMBL25028530 0.87 MAPT (0.46) ROCK2FAAHKDM4EMAPTSMN1; SMN2
SCHEMBL30895152 0.87 MAPT (0.46) ROCK2FAAHKDM4EMAPTSMN1; SMN2
SCHEMBL29979338 0.85 FAAH (0.41) FAAHKDM4EMAPTMEN1NPC1
SCHEMBL23769050 0.85 FAAH (0.41) FAAHKDM4EMAPTMEN1NPC1
SCHEMBL30895148 0.82 KDM4E (0.48) ROCK2FAAHDDB1CRBNKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118019738-A Small molecule urea derivatives as STING antagonists 库拉德夫制药私人有限公司 2024-05-10 CN claimed
US-20240360119-A1 SMALL MOLECULE UREA DERIVATIVES AS STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2024-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360119-A1 SMALL MOLECULE UREA DERIVATIVES AS STING ANTAGONISTS STING1, CGAS, SSB ROCK2 1718/4885FAAH 1194/4885DDB1 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.